PGP(18:1(11Z)/18:1(9Z))



Compound IDCDAMM02255
Common namePGP(18:1(11Z)/18:1(9Z))
IUPAC name[1-[hydroxy-(2-hydroxy-3-phosphonooxypropoxy)phosphoryl]oxy-3-octadec-11-enoyloxypropan-2-yl] octadec-9-enoate
Molecular formulaC42H80O13P2

Experimental data

Retention time15.04
Adduct[M+H]+
Actual mz855.514
Theoretical mz855.514
Error0.67
Ionizaton modePositive
Instrument typeLC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60
Score5.2294

Identifiers and class information

Inchi keyFWPPKNNEAMDSHQ-ZRXIRQNBSA-N
SmilesO=C(OCC(OC(=O)CCCCCCCC=CCCCCCCCC)COP(=O)(O)OCC(O)COP(=O)(O)O)CCCCCCCCCC=CCCCCCC
SuperclassLipids and lipid-like molecules
ClassGlycerophospholipids

Pharmacokinetic properties

Number of descriptor values(#stars)12
Number of non-conjugated amine groups (#amine)0
Number of amidine and guanidine groups (#amidine)0
Number of carboxylic acid groups (#acid)3
Number of non-conjugated amide groups (#amide)0
Number of rotatable bonds (#rotor)46
Number of reactive functional groups (#rtvFG)5
Predicted central nervous system activity (CNS)-2
Molecular weight (mol_MW)855.034
Computed dipole moment(dipole)3.829
Total solvent accessible surface area (SASA)1309.69
Hydrophobic component of SASA (FOSA)1032.21
Hydrophilic component of SASA (FISA)245.821
Pie component of the SASA (PISA)24.971
Weakly polar component of the SASA (WPSA)6.69
Total solvent accesible volume (volume)2720
Number of hydrogen bond donors (donorHB)4
Number of hydrogen bond acceptors (accptHB)15.7
Free energy of solvation of dipole (dip^2/V)0.005391
Index of cohesive interaction in solids (ACxDN^.5/SA)0.0239751
Globularity descriptor (glob)0.719518
Predicted polarizability in cubic angstroms (QPpolrz)73.402
Predicted hexadecane/gas partition coefficient (QPlogPC16)26.567
Predicted octanol/gas partition coefficient (QPlogPoct)38.173
Predicted water/gas partition coefficient (QPlogPw)15.891
Predicted octanol/water partition coefficient (QPlogPo/w)9.159
Predicted aqueous solubility (QPlogS)-6.146
Conformation-independent predicted aqueous solubility (CIQPlogS)-10.026
Predicted IC50 value for blockage of HERG K+ channels (QPlogHERG)-0.767
Predicted apparent Caco-2 cell permeability in nm/sec (QPPCaco)0.751
Predicted brain/blood partition coefficient (QPlogBB)-5.358
Predicted apparent MDCK cell permeability in nm/sec (QPPMDCK)0.465
Predicted skin permeability, log Kp (QPlogKp)-1.546
PM3 calculated ionization potential (IP(ev))9.781
PM3 calculated electron affinity (EA(eV))0.245
Number of likely metabolic reactions (#metab)7
Prediction of binding to human serum albumin (QPlogKhsa)0.179
Predicted qualitative human oral absorption (HumanOralAbsorption)1
Predicted human oral absorption on 0 to 100% scale (PercentHumanOralAbsorption)39.47
Solvent-accessible surface area of fluorine atoms (SAFluorine)0
Solvent-accessible surface area of amide oxygen atoms (SAamideO)0
Van der Waals surface area (PSA)206.376
Number of nitrogen and oxygen atoms (#NandO)13
Number of violations of Lipinski’s rule of five (RuleOfFive)3
Number of violations of Jorgensen’s rule of three (RuleOfThree)3

Compound-target network

Cytoscape Graph

Protein targets associated with phytocompound

Uniprot ID Gene name Target name TTD_ID Prediction source
P17612PRKACAcAMP-dependent protein kinase alpha-catalytic subunitT12808SEA
P34913EPHX2Epoxide hydrataseT35734SEA
O00519FAAHAnandamide amidohydrolaseT11754SEA
O00206TLR4Toll-like receptor 4 (by homology)T81443SEA
P15692VEGFAVascular endothelial growth factor AT20761SEA
P16109SELPP-selectinT10965SEA
Q9Y4D2DAGLASn1-specific diacylglycerol lipase alphaT03150SEA
Q9H228S1PR5Sphingosine 1-phosphate receptor Edg-8T50089SEA
P35813PPM1AProtein phosphatase 2C alphaT55260SEA
P52209PGD6-phosphogluconate dehydrogenaseT76497SEA
Q13822ENPP2AutotaxinT63512SEA
Q9HBW0LPAR2Lysophosphatidic acid receptor Edg-4T39380SEA
Q99500S1PR3Sphingosine 1-phosphate receptor Edg-3T11241SEA
P43657LPAR6Lysophosphatidic acid receptor 6T13484SEA
Q9H1C0LPAR5Lysophosphatidic acid receptor 5T18616SEA
O95136S1PR2Sphingosine 1-phosphate receptor Edg-5T47888SEA
O95977S1PR4Sphingosine 1-phosphate receptor Edg-6T17523SEA
O60906SMPD2Neutral sphingomyelinaseT57316SEA
Q9UPC5GPR34Probable G-protein coupled receptor 34T73859SEA
O00398P2RY10Putative P2Y purinoceptor 10T00488SEA
Q9BXC1GPR174Probable G-protein coupled receptor 174T87661SEA
Q9UBY5LPAR3Lysophosphatidic acid receptor Edg-7T95923SEA
Q92633LPAR1Lysophosphatidic acid receptor Edg-2T92640SEA
P16885PLCG2Phospholipase C-gamma-2T93922SEA
Q99677LPAR4Lysophosphatidic acid receptor 4T58130SEA
Q9UP65PLA2G4CCytosolic phospholipase A2 gammaT91113SEA
O60603TLR2Toll-like receptor 2T82078SEA

Target associated diseases

TTD_ID Disease_ID Disease name ICD_11 Uniprot ID Gene names
T12808DI0279Muscular atrophy[ICD-11: 8B61]P17612PRKACA
T35734DI0086Chronic obstructive pulmonary disease[ICD-11: CA22]P34913EPHX2
T35734DI0190Hypertension[ICD-11: BA00-BA04]P34913EPHX2
T11754DI0101Corneal disease[ICD-11: 9A76-9A78]O00519FAAH
T81443DI0022Allergic/hypersensitivity disorder[ICD-11: 4A80-4A8Z]O00206TLR4
T81443DI0346Prostate cancer[ICD-11: 2C82]O00206TLR4
T81443DI0375Sepsis[ICD-11: 1G40-1G41]O00206TLR4
T20761DI0095Colorectal cancer[ICD-11: 2B91]P15692VEGFA
T20761DI0365Retinopathy[ICD-11: 9B71]P15692VEGFA
T20761DI0430Vascular system developmental anomaly[ICD-11: LA90]P15692VEGFA
T10965DI0088Circulatory system disease[ICD-11: BE2Z]P16109SELP
T10965DI0381Sickle-cell disorder[ICD-11: 3A51]P16109SELP
T50089DI0275Multiple sclerosis[ICD-11: 8A40]Q9H228S1PR5
T55260DI0268Molluscum contagiosum[ICD-11: 1E76]P35813PPM1A
T76497DI0337Pituitary gland disorder[ICD-11: 5A60-5A61]P52209PGD
T63512DI0199Idiopathic interstitial pneumonitis[ICD-11: CB03]Q13822ENPP2
T11241DI0062Breast cancer[ICD-11: 2C60-2C6Y]Q99500S1PR3
T47888DI0419Ulcerative colitis[ICD-11: DD71]O95136S1PR2
T95923DI0146Fibrosis[ICD-11: GA14-GC01]Q9UBY5LPAR3
T95923DI0399Systemic sclerosis[ICD-11: 4A42]Q9UBY5LPAR3
T92640DI0146Fibrosis[ICD-11: GA14-GC01]Q92633LPAR1
T92640DI0199Idiopathic interstitial pneumonitis[ICD-11: CB03]Q92633LPAR1
T92640DI0351Psoriasis[ICD-11: EA90]Q92633LPAR1
T92640DI0399Systemic sclerosis[ICD-11: 4A42]Q92633LPAR1
T82078DI0346Prostate cancer[ICD-11: 2C82]O60603TLR2

Copyright © 2025